Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir…
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
October 31, 2025 16:05 ET | Source: Clover Health Investments, Corp. WILMINGTON,…
Ultima Markets and Inter Bring Their Partnership from Screen to Stadium
MILAN, Oct. 31, 2025 /PRNewswire/ -- Ultima Markets celebrated its Regional Partnership…
The global campaign ‘7 Wonders of Future Cities’ from New7Wonders starts on World Cities Day
DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority…
Saudi Arabia Redefines Wealth in Shift From Oil Dependence
RIYADH, Saudi Arabia, Oct. 30, 2025 /PRNewswire/ -- In an analytical article…
InSolare Energy Wins 600 MW / 1,200 MWh BESS Project from SECI — One of the Largest Standalone Awards to Date, Strengthening Its Leadership in Net Zero Infrastructure
InSolare, the 16-year-old clean energy leader extends its legacy of innovation with…
Solidion Technology Secures $1 Million Non-Dilutive Bridge Financing from Existing Shareholder
Company Reaffirms Commitment to Protect Shareholder Value and Pursue Strategic, Long-Term Capital…
Goyaz Secures Series A Investment from Norwest
HYDERABAD, India, Oct. 30, 2025 /PRNewswire/ -- Goyaz, India's fastest-growing occasion-led gold-plated silver…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
